nature.com search

Loading Filters

Showing 1–18 of 18 results

Loading Filters

1 April 1998
Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphoma
- L Mauvieux
- , D Canioni
- , O Hermine
- , F Valensi
- , I Radford-Weiss
- , M Azagury
- , M Magen
- , G Flandrin
- , N Brousse
- , B Varet
- & EA Macintyre
Leukemia 12 , 78–85

Rights & permissionsfor article Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphoma . Opens in a new window.
3 February 1998
BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line
- M Ahmed
- , I Dusanter-Fourt
- , M Bernard
- , P Mayeux
- , R G Hawley
- , T Bennardo
- , S Novault
- , M L Bonnet
- , S Gisselbrecht
- , B Varet
- & A G Turhan
Oncogene 16 , 489–496

Rights & permissionsfor article BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line . Opens in a new window.
Correspondence | 10 September 2003
Thalidomide therapy induces response in relapsed mantle cell lymphoma
- G Damaj
- , F Lefrère
- , R Delarue
- , B Varet
- , R Furman
- & O Hermine
Leukemia 17 , 1914–1915

Rights & permissionsfor article Thalidomide therapy induces response in relapsed mantle cell lymphoma . Opens in a new window.
Research | 6 March 2006
The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients
- F Lefrère
- , S Zohar
- , D Ghez
- , R Delarue
- , F Audat
- , F Suarez
- , O Hermine
- , G Damaj
- , N Maillard
- , J A Ribeil
- , M Azagury
- , R Misbahi
- , K Jondeau
- , M Cavazzana-Calvo
- , L Dal Cortivo
- & B Varet
Bone Marrow Transplantation 37 , 725–729

Rights & permissionsfor article The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients . Opens in a new window.
3 April 2000
Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes
- F Lefrère
- , O Hermine
- , C Belanger
- , S François
- , H Tilly
- , J-C Lebas de La Cour
- , F Valensi
- , B Varet
- & X Troussard
Leukemia 14 , 573–575

Rights & permissionsfor article Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes . Opens in a new window.
16 April 2009
LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome
- G Soler
- , S Nusbaum
- , B Varet
- , E A Macintyre
- , M Vekemans
- , S P Romana
- & I Radford-Weiss
Leukemia 23 , 1359–1361

Rights & permissionsfor article LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome . Opens in a new window.
Correspondence | 10 January 2005
Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis
- O Thaunat
- , M A Alyanakian
- , S Varnous
- , V Bors
- , G Damaj
- , J P Rerolle
- , K Jondeau
- , B Varet
- , I Gandjbakhch
- & A Buzyn
Bone Marrow Transplantation 35 , 419–420

Rights & permissionsfor article Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis . Opens in a new window.
Research | 16 March 2006
Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia
- V Asnafi
- , M-T Rubio
- , E Delabesse
- , E Villar
- , F Davi
- , G Damaj
- , I Hirsch
- , N Dhédin
- , J P Vernant
- , B Varet
- , A Buzyn
- & E Macintyre
Leukemia 20 , 793–799

Rights & permissionsfor article Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia . Opens in a new window.
Research | 8 November 1969
Neutralization of Graffi Leukaemia Virus
- J. P. LEVY
- , B. VARET
- , E. OPPENHEIM
- & J. C. LECLERC
Nature 224 , 606–608

Rights & permissionsfor article Neutralization of Graffi Leukaemia Virus . Opens in a new window.
Correspondence | 23 September 2004
Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update
- F Lefrère
- , V Lévy
- , S François
- , R Delarue
- , N Ifrah
- , H Tilly
- , F Valensi
- , X Troussard
- , B Varet
- & O Hermine
Leukemia 18 , 1924–1925

Rights & permissionsfor article Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update . Opens in a new window.
3 January 2003
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial
- S Keating
- , S Suciu
- , T de Witte
- , R Zittoun
- , F Mandelli
- , A Belhabri
- , S Amadori
- , W Fibbe
- , E Gallo
- , G Fillet
- , B Varet
- , G Meloni
- , A Hagemeijer
- , P Fazi
- , G Solbu
- & R Willemze
Leukemia 17 , 60–67

Rights & permissionsfor article The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial . Opens in a new window.
3 April 2000
Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7
- C Issaad
- , M Ahmed
- , S Novault
- , ML Bonnet
- , T Bennardo
- , B Varet
- , W Vainchenker
- & AG Turhan
Leukemia 14 , 662–670

Rights & permissionsfor article Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7 . Opens in a new window.
7 October 1999
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
- R Bouabdallah
- , F Lefrère
- , C Rose
- , P Chaïbi
- , J-L Harousseau
- , J-P Vernant
- , S Castaigne
- , F Bauduer
- , J-M Zini
- , D Coso
- , B Varet
- , J Robert
- & P Fenaux
Leukemia 13 , 1491–1496

Rights & permissionsfor article A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients . Opens in a new window.
Research | 19 October 2006
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group
- A-L Taksin
- , O Legrand
- , E Raffoux
- , T de Revel
- , X Thomas
- , N Contentin
- , R Bouabdallah
- , C Pautas
- , P Turlure
- , O Reman
- , C Gardin
- , B Varet
- , S de Botton
- , F Pousset
- , H Farhat
- , S Chevret
- , H Dombret
- & S Castaigne
Leukemia 21 , 66–71

Rights & permissionsfor article High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group . Opens in a new window.
Research | 22 November 2001
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient
- B Arnulf
- , F Chebbi
- , F Lefrere
- , Z Ait Arkoub
- , B Varet
- & AM Fillet
Bone Marrow Transplantation 28 , 799–801

Rights & permissionsfor article Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient . Opens in a new window.
Research | 1 May 1997
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia
- E Jourdan
- , D Maraninchi
- , J Reiffers
- , E Gluckman
- , B Rio
- , JP Jouet
- , M Michallet
- , L Molina
- , E Archimbaud
- , JL Harousseau
- , N Ifrah
- , M Attal
- , F Guilhot
- , M Kuentz
- , D Guyotat
- , JL Pico
- , C Dauriac
- , M Legros
- , F Dreyfus
- , P Bordigoni
- , V Leblond
- , N Gratecos
- , B Varet
- , C Auzanneau
- , H Tilly
- , E Vilmer
- , VJ Bardou
- & D Blaise
Bone Marrow Transplantation 19 , 875–881

Rights & permissionsfor article Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia . Opens in a new window.
16 April 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
- F Lefrère
- , A Delmer
- , F Suzan
- , V Levy
- , C Belanger
- , M Djabarri
- , B Arnulf
- , G Damaj
- , N Maillard
- , V Ribrag
- , M Janvier
- , C Sebban
- , R-O Casasnovas
- , R Bouabdallah
- , F Dreyfus
- , V Verkarre
- , E Delabesse
- , F Valensi
- , E McIntyre
- , N Brousse
- , B Varet
- & O Hermine
Leukemia 16 , 587–593

Rights & permissionsfor article Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study . Opens in a new window.
12 November 2010
Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling
- A-S Gabet
- , S Coulon
- , A Fricot
- , J Vandekerckhove
- , Y Chang
- , J-A Ribeil
- , L Lordier
- , Y Zermati
- , V Asnafi
- , Z Belaid
- , N Debili
- , W Vainchenker
- , B Varet
- , O Hermine
- & G Courtois
Cell Death and Differentiation 18 , 678–689

Rights & permissionsfor article Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling . Opens in a new window.

Refine your results by…

Filters

Filter By:

Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphoma

BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line

Thalidomide therapy induces response in relapsed mantle cell lymphoma

The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients

Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes

LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome

Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis

Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia

Neutralization of Graffi Leukaemia Virus

Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7

A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient

Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study

Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters